Gyre Therapeutics Inc. (GYRE) Live Share Price, Invest From India

Gyre Therapeutics Inc. Stock Performance

as on June 6, 2026 at 6:59 am IST

Day's Low
Day's High
$6.13
Day's Price Range
$6.66
$6.30
2.70%
Downside
5.71%
Upside
52 Week's Low
52 Week's High
$5.44
52-Week Price Range
$9.42
$6.30
13.65%
Downside
49.52%
Upside

Gyre Therapeutics Inc. share price movements today

Previous Close: $6.19
Open: $6.20
Volume: 234.0K
Day's Low - High: $6.13 - $6.66
52 Week Low - High: $5.44 - $9.42

Gyre Therapeutics Inc. Historical Returns

1 Month Return: -20.44 %
3 Month Return: -20.95 %
1 Year Return: -22.33 %
3 Year Return: 0 %
5 Year Return: 0 %

Gyre Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Gyre Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$552.1M

EPS (TTM)

-0.29

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

1.66%

PE Ratio (TTM)

PEG Ratio

EBITDA

5.1M

Revenue (TTM)

117.0M

Profit Margin

-5.44%

Return On Equity TTM

-3.08%

Gyre Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Gyre Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Gyre Therapeutics Inc.	SELL	$552.1M	NA	NA	-5.44%	NA
Revolution Medicines Inc	BUY	$32.2B	410.63%	NA	0.00%	NA
Alnylam Pharmaceuticals Inc	BUY	$39.1B	108.54%	73.51	12.55%	NA
Vertex Pharmaceuticals Inc	BUY	$108.7B	110.42%	25.45	35.51%	NA
Regeneron Pharmaceuticals Inc	BUY	$64.9B	22.83%	15.11	29.65%	0.59%

Stock Returns calculator for Gyre Therapeutics Inc. Stock including INR - Dollar returns

The Gyre Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Gyre Therapeutics Inc. investment value today

Current value as on today

₹87,427

Returns

-₹12,573

(-12.57%)

Returns from Gyre Therapeutics Inc. Stock

-₹20,954 (-20.95%)

Dollar Impact

₹8,380 (+8.38%)

Analyst Recommendation on Gyre Therapeutics Inc. Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Gyre Therapeutics Inc.. Average target price of $18.67

Gyre Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Gyre Therapeutics Inc..

What analysts predicted

66.26%UPSIDE

Target Price

$18.67

Current Price

$6.3

Analyzed by

6 Analysts

Target

$18.67

Gyre Therapeutics Inc. target price $18.67, a slight upside of 66.26% compared to current price of $6.3. According to 6 analysts rating.

Indian Investors' Interest in Gyre Therapeutics Inc. Stock

Search interest for Gyre Therapeutics Inc. Stock has increased by 113% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 7, 2026 to June 6, 2026

Change:113% versus previous 30 day period

Gyre Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	27	27	25	25	27	22	26	30	37	22
Gross Profit	25	26	24	24	26	21	25	28	35	21
Operating Income	-91	8	3	4	0	2	2	6	0	-9
EBITDA	-4	8	3	4	1	2	2	8	0	-9
Interest Expense	-	-	-	-	0	-	-	1	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-100	12	6	3	0	4	2	7	0	-9
Income Tax Expense	0	2	1	1	0	0	0	1	1	0
Net Income	-101	7	3	1	0	2	0	3	-1	-8
Net Profit Margin	-372.06%	27.72%	13.99%	4.41%	-0.36%	12.23%	1.65%	11.81%	-4.63%	-38.26%

Gyre Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	1	0	20	1	14	113	105	116
Gross Profit	-10	-11	-21	11	0	13	108	101	111
Operating Income	-20	-21	-33	-57	-83	9	-67	16	11
EBITDA	-16	-21	-33	-56	-87	10	20	17	14
Interest Expense	-	-	-	-	0	0	-	-	-
Depreciation	-	-	-	-	1	1	1	1	2
Income Before Tax	-16	-21	-30	-56	-87	9	-76	23	14
Income Tax Expense	3	0	3	0	0	5	8	5	4
Net Income	-16	-21	-30	-55	-13	0	-92	12	5
Net Profit Margin	-4246.87%	-2117.98%	-500916.67%	-265.14%	-1198.32%	2.25%	-81.92%	11.43%	4.31%

Gyre Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	9	3	1	0	3	1	5	-2	-8
Operating Cash Flow	2	-5	1	-2	0	2	4	-5	3
Investing Cash Flow	-7	-8	-2	-2	1	-3	-1	1	-3
Financing Cash Flow	0	0	0	0	1	22	0	0	0
Change in Cash	-3	-13	0	-4	3	21	3	-3	0

Gyre Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-21	-30	-55	-56	-87	4	-85	17	9
Operating Cash Flow	-19	-28	-43	-55	-83	10	25	-3	1
Investing Cash Flow	-11	-71	27	9	48	-13	-19	-19	0
Financing Cash Flow	35	111	0	60	49	-45	2	2	24
Change in Cash	4	11	-15	14	13	-5	8	-21	25

Global Institutional Holdings in Gyre Therapeutics Inc.

Funds	Holdings
UBS Group AG	0.02%
Rhumbline Advisers	0.01%
State Of Wisconsin Investment Board	0.03%
Deutsche Bank AG	0.01%
BlackRock Inc	0.78%

See all

Insights on Gyre Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 287.3% return, outperforming this stock by 309.6%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 37.19M → 22.51M (in $), with an average decrease of 39.5% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, 3.61M → -8.61M (in $), with an average decrease of 273.9% per quarter
NEGATIVE IMPACT
Price Dip
In the last 1 month, GYRE stock has moved down by -20.4%

About Gyre Therapeutics Inc.

Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. The company offers ETUARY (Pirfenidone), an anti-fibrotic drug approved for the treatment of idiopathic pulmonary fibrosis; and under Phase 3 trials for the treatment of pneumoconiosis. It is also involved in the development of F351 (Hydronidone), a structural derivative of ETUARY, under Phase 3 trials for the treatment of chronic hepatitis B (CHB)-associated liver fibrosis; and completed Phase 1 trials for the treatment of liver fibrosis associated with metabolic dysfunction-associated steatohepatitis. In addition, the company develops F573 is in Phase 2 clinical trials for the treatment of acute/acute-on-chronic liver failure. Further, its preclinical products include F230 for the treatment of pulmonary arterial hypertension; and F528 to treat chronic obstructive pulmonary disease. Gyre Therapeutics, Inc. was founded in 2002 and is headquartered in San Diego, California. Gyre Therapeutics, Inc. operates as a subsidiary of GNI USA, Inc.

Organisation	Gyre Therapeutics Inc.
Headquarters	12770 High Bluff Drive, San Diego, CA, United States, 92130
Industry	Biotechnology
CEO	Dr. Ying Luo Ph.D.
E-voting on shares	Click here to vote

Key Management of Gyre Therapeutics Inc.

Name	Title
Dr. Ying Luo Ph.D.	CEO, President & Director
Mr. Joshua Bergmann J.D.	General Counsel & Corporate Secretary
Seth Goldblum M.B.A.	Senior Vice President of Corporate Development
Mr. Jialiang Wang Ph.D.	Executive VP & GM
Jing Liu Ph.D.	Senior Vice President of Platform Chemistry
Mr. Thomas W. Eastling M.D.	Chief Financial Officer
Ms. Ruoyu Chen	Chief Information Officer
Dr. Yue Xiong Ph.D.	Chief Scientific Officer
Mark Marino	Senior Vice President of Clinical Development
Mr. Weiguo Ye	Chief Operating Officer

FAQs

What is Gyre Therapeutics Inc. share price today?

Gyre Therapeutics Inc. share price today is $6.3 as on June 6, 2026 at 1:29 am IST at the close of the market. Gyre Therapeutics Inc. share today touched a day high of $6.66 and a low of $6.13.

What is the 52 week high and 52 week low for Gyre Therapeutics Inc. share?

Gyre Therapeutics Inc. share touched a 52 week high of $9.42 on October 16, 2025 and a 52 week low of $5.44 on June 2, 2026. Gyre Therapeutics Inc. stock price today i.e. June 6, 2026 at 1:29 am IST is closed at $6.3,which is 33.12% down from its 52 week high and 15.81% up from its 52 week low.

What is Gyre Therapeutics Inc.'s market capitalisation today?

Gyre Therapeutics Inc. market capitalisation is $0.00T as on June 6, 2026 at 1:29 am IST.

How to invest in Gyre Therapeutics Inc. Stock (GYRE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Gyre Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Gyre Therapeutics Inc. Shares that will get you 0.2381 shares as per Gyre Therapeutics Inc. share price of $6.3 per share as on June 6, 2026 at 1:29 am IST.

What is the minimum amount required to buy Gyre Therapeutics Inc. Stock (GYRE) from India?

Indian investors can start investing in Gyre Therapeutics Inc. (GYRE) shares with as little as ₹94.935 or $1 (as of June 6, 2026 at 8:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.35 in Gyre Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on June 6, 2026 at 8:41 am IST). Based on Gyre Therapeutics Inc. share’s latest price of $6.3 as on June 6, 2026 at 1:29 am IST, you will get 1.5873 shares of Gyre Therapeutics Inc.. Learn more about fractional shares .